AIFM2 and cancer: Notably, certain cancer cells exhibit intrinsic high vulnerability to GPX4 inhibition5,6 in synergism with inhibition of ferroptosis-suppressor protein 1 (FSP1),7,8,9,10,11,12 the second guardian of ferroptosis.